Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CBZ | LBTYK |
|---|---|---|
| Price | $54.72 | $8.80 |
| Change today | ▲ 0.05% | ▲ 0.57% |
| Market cap | $3.01B | $3.00B |
| Return, 3 months | +47.9% | -15.9% |
| Return, year to date | +8.5% | -20.3% |
| Return, 1 year | -2.4% | -24.2% |
| P/E (TTM) | 26.3 | -1.0 |
| P/B | 1.6 | 0.3 |
| P/E percentile vs own 5y | 50th | 55th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -0.2% | +12.4% |
| Net profit growth (YoY) | -55.6% | -531.2% |
| Gross margin | 12.2% | 65.8% |
| Operating margin | 6.9% | 1.4% |
| Net margin | 4.4% | -145.5% |
| Return on equity | 6.5% | – |
| Analyst target vs. price | +0.5% | +104.5% |
| Analyst buy share | 0% | 100% |
| RSI (14) | 69 | 25 |
| 30-day volatility | 3.2% | 24.5% |
| Max drawdown, 1 year | -55.7% | -30.9% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.